N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine

C99H77F16N25O2 — CID 157116096

IUPACN-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine
SMILESCN1CCN(c2cccc3c(Nc4n[nH]c5c(F)cccc45)nc(-c4ccccc4C(F)(F)F)nc23)CC1.FC(F)(F)c1ccccc1-c1nc(Nc2n[nH]c3ccccc23)c2cccc(N3CCOCC3)c2n1.Fc1cc(F)c2[nH]nc(Nc3nc(-c4ccccc4C(F)(F)F)nc4ccc(N5CCOCC5)cc34)c2c1.Fc1cccc2c(Nc3nc(-c4ccccc4C(F)(F)F)nc4c3CNC4)n[nH]c12
InChIInChI=1S/C27H23F4N7.C26H19F5N6O.C26H21F3N6O.C20H14F4N6/c1-37-12-14-38(15-13-37)21-11-5-8-18-23(21)32-24(16-6-2-3-9-19(16)27(29,30)31)33-25(18)34-26-17-7-4-10-20(28)22(17)35-36-26;27-14-11-18-22(20(28)12-14)35-36-25(18)34-24-17-13-15(37-7-9-38-10-8-37)5-6-21(17)32-23(33-24)16-3-1-2-4-19(16)26(29,30)31;27-26(28,29)19-9-3-1-6-16(19)23-30-22-18(8-5-11-21(22)35-12-14-36-15-13-35)24(31-23)32-25-17-7-2-4-10-20(17)33-34-25;21-14-7-3-5-11-16(14)29-30-19(11)28-18-12-8-25-9-15(12)26-17(27-18)10-4-1-2-6-13(10)20(22,23)24/h2-11H,12-15H2,1H3,(H2,32,33,34,35,36);1-6,11-13H,7-10H2,(H2,32,33,34,35,36);1-11H,12-15H2,(H2,30,31,32,33,34);1-7,25H,8-9H2,(H2,26,27,28,29,30)
InChIKeyAHKPWNJZCDYEKM-UHFFFAOYSA-N
MW1952.85 g/mol
LogP22.17
Rot. Bonds15

About N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine

N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine (PubChem CID 157116096) has the molecular formula C99H77F16N25O2 and a molecular weight of 1952.85 g/mol. Its IUPAC name is N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine.

Molecular Properties

Compound NameN-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine
PubChem CID157116096
Molecular FormulaC99H77F16N25O2
Molecular Weight1952.85 g/mol
Exact Mass1951.64
IUPAC NameN-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine
SMILESCN1CCN(c2cccc3c(Nc4n[nH]c5c(F)cccc45)nc(-c4ccccc4C(F)(F)F)nc23)CC1.FC(F)(F)c1ccccc1-c1nc(Nc2n[nH]c3ccccc23)c2cccc(N3CCOCC3)c2n1.Fc1cc(F)c2[nH]nc(Nc3nc(-c4ccccc4C(F)(F)F)nc4ccc(N5CCOCC5)cc34)c2c1.Fc1cccc2c(Nc3nc(-c4ccccc4C(F)(F)F)nc4c3CNC4)n[nH]c12
InChIInChI=1S/C27H23F4N7.C26H19F5N6O.C26H21F3N6O.C20H14F4N6/c1-37-12-14-38(15-13-37)21-11-5-8-18-23(21)32-24(16-6-2-3-9-19(16)27(29,30)31)33-25(18)34-26-17-7-4-10-20(28)22(17)35-36-26;27-14-11-18-22(20(28)12-14)35-36-25(18)34-24-17-13-15(37-7-9-38-10-8-37)5-6-21(17)32-23(33-24)16-3-1-2-4-19(16)26(29,30)31;27-26(28,29)19-9-3-1-6-16(19)23-30-22-18(8-5-11-21(22)35-12-14-36-15-13-35)24(31-23)32-25-17-7-2-4-10-20(17)33-34-25;21-14-7-3-5-11-16(14)29-30-19(11)28-18-12-8-25-9-15(12)26-17(27-18)10-4-1-2-6-13(10)20(22,23)24/h2-11H,12-15H2,1H3,(H2,32,33,34,35,36);1-6,11-13H,7-10H2,(H2,32,33,34,35,36);1-11H,12-15H2,(H2,30,31,32,33,34);1-7,25H,8-9H2,(H2,26,27,28,29,30)
InChIKeyAHKPWNJZCDYEKM-UHFFFAOYSA-N
XLogP22.17
TPSA309.41 Ų
H-Bond Donors9
H-Bond Acceptors23
Rotatable Bonds15
Heavy Atoms142
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001952.85
LogP ≤ 522.17
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1023

Analyze N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine?
The IUPAC name of N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine (CID 157116096) is N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine.
What is the SMILES notation for N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine?
The canonical SMILES for N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine is CN1CCN(c2cccc3c(Nc4n[nH]c5c(F)cccc45)nc(-c4ccccc4C(F)(F)F)nc23)CC1.FC(F)(F)c1ccccc1-c1nc(Nc2n[nH]c3ccccc23)c2cccc(N3CCOCC3)c2n1.Fc1cc(F)c2[nH]nc(Nc3nc(-c4ccccc4C(F)(F)F)nc4ccc(N5CCOCC5)cc34)c2c1.Fc1cccc2c(Nc3nc(-c4ccccc4C(F)(F)F)nc4c3CNC4)n[nH]c12.
What is the InChIKey of N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine?
The InChIKey is AHKPWNJZCDYEKM-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H23F4N7.C26H19F5N6O.C26H21F3N6O.C20H14F4N6/c1-37-12-14-38(15-13-37)21-11-5-8-18-23(21)32-24(16-6-2-3-9-19(16)27(29,30)31)33-25(18)34-26-17-7-4-10-20(28)22(17)35-36-26;27-14-11-18-22(20(28)12-14)35-36-25(18)34-24-17-13-15(37-7-9-38-10-8-37)5-6-21(17)32-23(33-24)16-3-1-2-4-19(16)26(29,30)31;27-26(28,29)19-9-3-1-6-16(19)23-30-22-18(8-5-11-21(22)35-12-14-36-15-13-35)24(31-23)32-25-17-7-2-4-10-20(17)33-34-25;21-14-7-3-5-11-16(14)29-30-19(11)28-18-12-8-25-9-15(12)26-17(27-18)10-4-1-2-6-13(10)20(22,23)24/h2-11H,12-15H2,1H3,(H2,32,33,34,35,36);1-6,11-13H,7-10H2,(H2,32,33,34,35,36);1-11H,12-15H2,(H2,30,31,32,33,34);1-7,25H,8-9H2,(H2,26,27,28,29,30).
What are the key properties of N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine?
N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine has a molecular weight of 1952.85 g/mol, XLogP of 22.17, 15 rotatable bonds, 9 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine is sourced from PubChem (CID 157116096), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).